Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 72.32% vs -10.32% in Jun 2026
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 380.77% vs -82.55% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 72.63% vs -52.50% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 10.00% vs -16.67% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Genpharmasec With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 72.32% vs -10.32% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 162.44% vs 441.29% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 380.77% vs -82.55% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 205.93% vs -268.57% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 72.63% vs -52.50% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 448.94% vs -491.67% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 10.00% vs -16.67% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 91.30% vs 228.57% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025